NovoCure Limited (NVCR) Gross profit 2017–2026
NovoCure Limited (NVCR) annual gross profit history from SEC filings — each fiscal year as reported.
$488.5MFY2026 · since FY2017: $36.6M → $488.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $488.5M | +4.4% |
| FY2025 | $468.0M | +22.8% |
| FY2024 | $381.1M | -9.9% |
| FY2023 | $423.0M | +0.7% |
| FY2022 | $420.2M | +8.3% |
| FY2021 | $387.9M | +47.6% |
| FY2020 | $262.7M | +56.4% |
| FY2019 | $168.0M | +38.4% |
| FY2018 | $121.4M | +231.7% |
| FY2017 | $36.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NVCR financial trends
NVCR RevenueNVCR Net incomeNVCR Net marginNVCR Gross marginNVCR Operating incomeNVCR Operating marginNVCR Operating cash flowNVCR Free cash flowNVCR Capital expendituresNVCR Return on equityNVCR Stock buybacksNVCR Dividends paidNVCR Total assetsNVCR Total liabilitiesNVCR Shareholders’ equityNVCR overview →